PropertyValue
nif:beginIndex
  • 0 (xsd:integer)
nif:broaderContext
nif:endIndex
  • 186 (xsd:integer)
nif:isString
  • As evaluated by MTT assays, gefitinib (EGFR inhibitor) and DIM-C (PPARĪ³ agonist) inhibited growth of 9 bladder cancer cell lines in a dose-dependent manner but with variable sensitivity.
rdf:type